Association of sulfonylurea receptor 1 genotype with therapeutic response to gliclazide in type 2 diabetes

This publication has 15 references indexed in Scilit:

• Role of impaired insulin secretion and insulin resistance in the pathogenesis of type 2 diabetes mellitus
  Comprehensive Therapy, 2005
• Genetics of type 2 diabetes mellitus
  Diabetes Research and Clinical Practice, 2005
• PRIMARY PREVENTION OF DIABETES: What Can Be Done and How Much Can Be Prevented?
  Annual Review of Public Health, 2005
• A new subtype of autosomal dominant diabetes attributable to a mutation in the gene for sulfonylurea receptor 1
  The Lancet, 2003
• A serine/alanine polymorphism in the nucleotide‐binding fold‐2 of the sulphonylurea receptor‐1 (S1369A) is associated with enhanced glucose‐induced insulin secretion during pregnancy
  Journal of Inherited Metabolic Disease, 2000
• Association of a variant in exon 31 of the sulfonylurea receptor 1 (SUR1) gene with type 2 diabetes mellitus in French Caucasians
  Human Genetics, 2000
• Tissue-specific effects of sulfonylureas
  Journal of Diabetes and its Complications, 2000
• Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin.
  Diabetes Care, 2000
• Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
  Diabetes, 1998
• The impact of pharmacogenetics on the future of healthcare
  Current Opinion in Biotechnology, 1997